Hepatitis G

Genelabs Technologies, University of Iowa Research Foundation collaborate on HGV, HIV research

Published in Hepatitis Weekly, June 3rd, 2002

Genelabs Technologies, Inc., (GNLB) announced that it has entered into a collaboration with the University of Iowa Research Foundation (UIRF) to study the impact of the hepatitis G virus (HGV, also known as GB virus C, or GBV-C) on human immunodeficiency virus (HIV) infection.

On September 6, 2001, Jack T. Stapleton, MD, professor of medicine at the University of Iowa Roy J. and Lucille A. Carver College of Medicine and Director of the Helen C. Levitt Center for Viral Pathogenesis and Disease, and his colleagues published "Effect of Coinfection with GB Virus C on Survival Among Patients with HIV Infection" in the New England Journal of Medicine....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-06-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry